Macrophage-neutrophil crosstalk via the Selplg-Sell-YAP axis drives NETosis and MASH-associated liver fibrosis
Listen to this summary
The authors investigate the immune mechanisms underlying the transition from inflammation to fibrosis in metabolic dysfunction-associated steatohepatitis (MASH), specifically focusing on the crosstalk between macrophages and neutrophils. They identify the Selplg-Sell-YAP signaling axis as a key driver of neutrophil extracellular trap (NET) formation, which subsequently activates hepatic stellate cells and promotes fibrosis. The study suggests that targeting this axis could offer therapeutic potential for MASH-associated liver fibrosis.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Hepatology (Baltimore, Md.)
View all →Jun 10, 2026 · Hepatology (Baltimore, Md.)
Vitamin E dosing study (VEDS) in patients with metabolic dysfunction-associated steatotic liver disease with elevated aminotransferases: A multicenter, randomized, placebo-controlled trial
Jun 9, 2026 · Hepatology (Baltimore, Md.)
HBsAg seroclearance further reduces hepatocellular carcinoma but not hepatic decompensation in patients with cirrhosis and complete viral suppression
More in Internal Medicine
View all →Sep 23, 2026 · JACC. Clinical electrophysiology
Programmed Ventricular Stimulation for Risk Stratification in Nonischemic Cardiomyopathy With Preserved or Mildly Reduced LVEF
Sep 23, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer
Sep 23, 2026 · American journal of respiratory and critical care medicine
Biologic outcomes in severe asthma patients by smoking status: evidence from SHARP
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · American journal of respiratory and critical care medicine
Combined results of the TETON-1 and TETON-2 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


